Home › Prostate Cancer › Texas › Fort Worth
Prostate Cancer clinical trials in Fort Worth, TX
10 studies for Prostate Cancer are looking for participants at sites in and around Fort Worth (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RecruitingPhase 3
- Tarrant County Hospital District/JPS Health Network, Fort Worth
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
RecruitingPhase 2
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
RecruitingPhase 3
- Urology Partners of North Texas (UPNT), Fort Worth
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
RecruitingPhase 3
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
RecruitingPhase 3
- Research Site, Fort Worth
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
RecruitingPhase 3
- University of Texas Southwestern Simmons Cancer Center - Fort Worth, Fort Worth
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RecruitingPhase 3
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 1
- START Dallas-Fort Worth, Fort Worth
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
RecruitingPhase 1
- START Dallas, Fort Worth
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY101 studies
- Houston, TX73 studies
- Los Angeles, CA64 studies
- Boston, MA56 studies
- Seattle, WA45 studies
- St. Louis, MO45 studies
- Chicago, IL45 studies
- Baltimore, MD45 studies
- San Francisco, CA44 studies
- Philadelphia, PA41 studies
- Nashville, TN40 studies
- Washington, DC39 studies
Other studies in Fort Worth
- Non-Small Cell Lung Cancer20 studies
- Ovarian Cancer19 studies
- Breast Cancer14 studies
- Endometrial Cancer11 studies
- Cancer (all types)10 studies
- Heart Failure8 studies
- Metastatic Cancer8 studies
- Ulcerative Colitis8 studies
- Kidney Cancer (Renal Cell Carcinoma)7 studies
- Triple-Negative Breast Cancer7 studies
- Obesity7 studies
- Macular Degeneration6 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.